4.5 Article

Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma

Journal

RESPIRATORY MEDICINE
Volume 107, Issue 9, Pages 1339-1345

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.rmed.2013.06.014

Keywords

Asthma; VEGF; Cysteinyl leukotrienes; Inflammation; Angiogenesis; Vascular remodeling

Ask authors/readers for more resources

Background: Vascular endothelial growth factor (VEGF) is considered to be the most important angiogenic factor in asthma. Cysteinyl leukotrienes (Cyst-LTs) have been implicated in vascular permeability in asthma. Cyst-LTs receptor antagonists modulate vascular permeability by reducing VEGF expression. Objective: We aimed to determine the levels of VEGF and Cyst-LTs in sputum supernatants of patients with asthma and to investigate possible associations within them and with airway vascular permeability (AVP) index. Possible confounding factors were also assessed. Methods: One hundred twenty one patients with asthma (38 with severe refractory asthma, 41 smokers) and 30 healthy subjects (15 smokers) were studied. All subjects underwent lung function tests, and sputum induction for cell count identification and VEGF, Cyst-LTs, measurement in supernatants. AVP index was also assessed. Results: Both VEGF & Cyst-LTs (pg/ml) levels were significantly elevated in patients with asthma compared to normal subjects (median, interquartile ranges 845 [487-1034] vs. 432 (327-654) and 209 [171-296] vs. 92 [75-114] respectively, p < 0.001 for both). Multivariate regression analysis in the whole group showed a significant association of Cyst-LTs levels in sputum supernatants with VEGF levels in sputum supernatants and AVP index. A similar positive association was observed between VEGF levels in sputum supernatants and AVP index. The presence of Severe asthma was a significant covariate for both associations. Conclusion: Our results indicate that Cyst-LTs may modulate vascular permeability by up-regulating VEGF expression. The above effect seems to be affected by asthma severity. (C) 2013 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Microalbuminuria on admission for acute exacerbation of COPD as a predictor of all-cause mortality and future exacerbations

Konstantinos Bartziokas, Christos Kyriakopoulos, Evangelia Dounousi, Konstantinos Kostikas

Summary: The presence of MAB in patients with AECOPD is associated with more severe COPD, prolonged hospitalization, and increased risk of AECOPD and mortality at 1-year follow-up.

POSTGRADUATE MEDICAL JOURNAL (2023)

Letter Respiratory System

Untitled - Reply

Christos Kyriakopoulos, Athena Gogali, Georgios Ntritsos, Haralampos Milionis, Evangelos Evangelou, Konstantinos Kostikas

RESPIROLOGY (2022)

Article Medicine, General & Internal

The Diagnostic Role of Uric Acid to Creatinine Ratio for the Identification of Patients with Adverse Pulmonary Embolism Outcomes

Konstantinos Bartziokas, Christos Kyriakopoulos, Dimitrios Potonos, Konstantinos Exarchos, Athena Gogali, Konstantinos Kostikas

Summary: This study investigated the potential value of the UA/Cr ratio as a diagnostic tool for the prognosis of patients with acute pulmonary embolism (PE) and its correlation with other parameters. The results showed that UA/Cr levels are associated with disease severity and risk stratification, and may serve as a useful biomarker for identifying patients at risk of adverse outcomes.

DIAGNOSTICS (2022)

Article Medicine, General & Internal

The Role of Digital Tools in the Timely Diagnosis and Prevention of Acute Exacerbations of COPD: A Comprehensive Review of the Literature

Athanasios Konstantinidis, Christos Kyriakopoulos, Georgios Ntritsos, Nikolaos Giannakeas, Konstantinos I. Gourgoulianis, Konstantinos Kostikas, Athena Gogali

Summary: COPD exacerbations have significant negative impacts on patients' health and quality of life, as well as economic burden. The COVID-19 pandemic has led to an increased demand for telemedicine services. This review aims to evaluate the effectiveness of telemedicine in managing COPD exacerbations and provides a detailed description of the specific telemedicine interventions used.

DIAGNOSTICS (2022)

Article Health Care Sciences & Services

Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity

Petros Bakakos, Konstantinos Kostikas, Stelios Loukides, Michael Makris, Nikolaos G. Papadopoulos, Paschalis Steiropoulos, Stavros Tryfon, Eleftherios Zervas

Summary: Asthma, a chronic inflammatory airway disease, has a significant impact on public health worldwide. Recent changes in the management of mild and severe asthma include the use of as-needed treatment with inhaled corticosteroids and fast-acting bronchodilators for mild asthma, and the reduction of oral steroids through the use of biologics for severe asthma. However, biologics are currently only available for a subset of severe asthmatics with a T2-high endotype.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Respiratory System

Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis

Efthymia Papadopoulou, Jan Hansel, Zsofia Lazar, Konstantinos Kostikas, Stavros Tryfon, Jurgen Vestbo, Alexander G. Mathioudakis

Summary: This meta-analysis explored the safety and effectiveness of mucolytics as an add-on treatment for COPD exacerbations. The analysis included 24 RCTs involving 2192 patients and showed that mucolytics can increase treatment success rate, improve symptom scores, reduce persistent cough, and facilitate expectoration. There is also some evidence suggesting that mucolytics may reduce future exacerbation risk and improve quality of life.

EUROPEAN RESPIRATORY REVIEW (2023)

Letter Respiratory System

Latent COPD: a proposed new term in the disease nomenclature

Athena Gogali, Konstantinos Kostikas

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study

Richard N. Van Zyl-Smit, Huib AM. Kerstjens, Jorge F. Maspero, Konstantinos Kostikas, Motoi Hosoe, Ana-Maria Tanase, Peter Andrea, Karen Mezzi, Dominic Brittain, David Lawrence, Kenneth R. Chapman

Summary: This study evaluated the efficacy of a fixed-dose combination therapy of mometasone furoate/indacaterol acetate/glycopyrronium bromide in asthma patients with and without persistent airflow limitation. The results showed that this therapy improved lung function and reduced asthma exacerbations in patients with airflow limitation.

RESPIRATORY MEDICINE (2023)

Article Health Care Sciences & Services

Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations

Konstantinos Bartziokas, Evgenia Papathanasiou, Andriana I. I. Papaioannou, Ilias Papanikolaou, Emmanouil Antonakis, Ioanna Makou, Georgios Hillas, Theodoros Karampitsakos, Ourania Papaioannou, Katerina Dimakou, Vasiliki Apollonatou, Galateia Verykokou, Spyros Papiris, Petros Bakakos, Stelios Loukides, Konstantinos Kostikas

Summary: In recent years, blood eosinophils have been studied as a biomarker for eosinophilic airway inflammation and a prognostic indicator for COPD outcomes. This study found that low blood eosinophil levels upon admission for COPD exacerbation were associated with more severe disease and predicted the need for NIV. Further research is needed to confirm the use of blood eosinophil levels as a predictor of unfavorable outcomes.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

What is the real incidence of right ventricular affection in patients with acute pulmonary embolism?

Christos Ballas, Lampros Lakkas, Olga Kardakari, Athanasios Konstantinidis, Konstantinos Exarchos, Stavroula Tsiara, Konstantinos Kostikas, Katerina K. Naka, Lampros K. Michalis, Christos S. Katsouras

Summary: This study evaluated non-conventional markers of right ventricular dysfunction in patients with acute pulmonary embolism. The results showed that a majority of patients had abnormal right ventricular function, which was associated with clinical and biochemical prognostic indices.

ACTA CARDIOLOGICA (2023)

Article Cardiac & Cardiovascular Systems

Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study

Konstantinos Kostikas, Jorge F. Maspero, Kenneth R. Chapman, Karen Mezzi, Xavier Jaumont, David Lawrence, Richard van Zyl-Smit

Summary: This study evaluated the impact of baseline eosinophil levels on the efficacy of mometasone/indacaterol/glycopyrronium in patients with asthma. The results showed that eosinophil levels did not affect the effectiveness of the medication.

RESPIRATORY MEDICINE (2023)

Letter Respiratory System

Lung function and exacerbations in patients with COPD escalated to triple therapy: The RETRIEVE real-world study

Stavros Tryfon, Efthymia Papadopoulou, Maria Bertoli, Konstantinos Exarchos, Alexandros Ginis, Konstantinos Kostikas

RESPIROLOGY (2023)

Article Medicine, General & Internal

Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality

Vagia Karageorgou, Andriana I. Papaioannou, Maria Kallieri, Myrto Blizou, Stefanos Lampadakis, Maria Sfika, Antonios Krouskos, Vasileios Papavasileiou, Franceska Strakosha, Kalliopi Theoni Vandorou, Pavlos Siozos, Marina Moustaka Christodoulou, Georgia Kontonasiou, Vasiliki Apollonatou, Elvira Markella Antonogiannaki, Christos Kyriakopoulos, Christina Aggelopoulou, Christos Chronis, Konstantinos Kostikas, Evangelia Koukaki, Zoi Sotiropoulou, Athanasia Athanasopoulou, Petros Bakakos, Pinelopi Schoini, Emmanouil Alevrakis, Sotirios Poupos, Evangelia Chondrou, Dionisios Tsoukalas, Alexia Chronaiou, George Tsoukalas, Sofia Koukidou, Georgios Hillas, Katerina Dimakou, Konstantinos Roukas, Ifigeneia Nakou, Diamantis Chloros, Evangelia Fouka, Spyros A. Papiris, Stelios Loukides

Summary: This study compared the baseline characteristics of patients in two phases of the COVID-19 pandemic and evaluated possible predictors of mortality. The study found that patients in the Delta period were younger, required a longer duration of hospitalization, and had more severe disease compared to patients in the Omicron period. The study identified independent predictors of mortality for patients in both periods.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Chemistry, Analytical

Solid-Phase Microextraction (SPME) and Gas Chromatographic/Mass Spectrometry in Chronic Obstructive Pulmonary Disease (COPD): A Chemometric Approach

Loukia Lypirou, Christos Chronis, Konstantinos Exarchos, Konstantinos Kostikas, Vasilios Sakkas

Summary: This study analyzed volatile organic compounds (VOCs) in exhaled breath of COPD patients using gas chromatography/mass spectrometry, and identified certain molecules associated with the risk of future COPD exacerbation. This provides a promising avenue for the detection and management of COPD.

CHEMOSENSORS (2023)

No Data Available